Moser Wealth Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-10,465
Closed -$915K 141
2021
Q4
$915K Hold
10,465
0.55% 41
2021
Q3
$856K Buy
10,465
+1,150
+12% +$103K 0.55% 45
2021
Q2
$850K Sell
9,315
-1,525
-14% -$136K 0.55% 44
2021
Q1
$927K Buy
10,840
+25
+0.2% +$2.24K 0.65% 39
2020
Q4
$1.02M Hold
10,815
0.75% 32
2020
Q3
$940K Sell
10,815
-75
-0.7% -$6.5K 0.75% 29
2020
Q2
$951K Hold
10,890
0.91% 28
2020
Q1
$898K Sell
10,890
-175
-2% -$15.6K 1.04% 24
2019
Q4
$1.05M Buy
+11,065
New +$993K 1.01% 22

Other funds holding NVS

Moser Wealth Advisors's NVS Position: Q1 2022 in Review

Moser Wealth Advisors sold out of Novartis (NVS) in Q1 2022, closing a stake of 10,465 shares — an estimated $915K sold.

Moser Wealth Advisors first reported a position in NVS in Q4 2019 and held it in 9 quarters. The position peaked at $1.05M in Q4 2019. 1,136 funds tracked by Wall St. Rank hold NVS as of Q1 2022.

  • Moser Wealth Advisors reported no remaining Novartis position as of Q1 2022 after selling out during the quarter.
  • Moser Wealth Advisors sold 10,465 Novartis shares in Q1 2022, an estimated $915K.
  • Moser Wealth Advisors first reported a position in Novartis in Q4 2019 and held it in 9 quarters.
  • Moser Wealth Advisors's Novartis position peaked at $1.05M in Q4 2019.
  • 1,136 funds tracked by Wall St. Rank held Novartis as of Q1 2022.

Based on Moser Wealth Advisors's 13F filing for Q1 2022, filed 29 Apr 2022.